Literature DB >> 9039558

Enterobacter sakazakii: a review.

M Nazarowec-White1, J M Farber.   

Abstract

Enterobacter sakazakii, previously referred to as a yellow-pigmented Enterobacter cloacae was designated as a unique species in 1980. This reclassification was based on differences from E. cloacae in DNA relatedness, pigment production and biochemical reactions. E. sakazakii has been implicated in a severe form of neonatal meningitis. Although studies have failed to identify an environmental source for the organism, dried-infant formula has been implicated in both outbreaks and sporadic cases of E. sakazakii meningitis. The high mortality rate (40-80%), the severity of the infection in infants, plus the scarcity of information on the ecology and pathogenicity of this organism warranted a review of the clinical and microbiological features of this putative foodborne pathogen.

Entities:  

Mesh:

Year:  1997        PMID: 9039558     DOI: 10.1016/s0168-1605(96)01172-5

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  45 in total

1.  Inoculum size influences bacterial cross contamination between surfaces.

Authors:  R Montville; D W Schaffner
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

2.  Complete genome sequence of Cronobacter sakazakii temperate bacteriophage phiES15.

Authors:  Ju-Hoon Lee; Younho Choi; Hakdong Shin; Junghyun Lee; Sangryeol Ryu
Journal:  J Virol       Date:  2012-07       Impact factor: 5.103

3.  Characterization of putative virulence genes on the related RepFIB plasmids harbored by Cronobacter spp.

Authors:  A A Franco; L Hu; C J Grim; G Gopinath; V Sathyamoorthy; K G Jarvis; C Lee; J Sadowski; J Kim; M H Kothary; B A McCardell; B D Tall
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

4.  Dissemination of Cronobacter spp. (Enterobacter sakazakii) in a powdered milk protein manufacturing facility.

Authors:  N Mullane; B Healy; J Meade; P Whyte; P G Wall; S Fanning
Journal:  Appl Environ Microbiol       Date:  2008-07-18       Impact factor: 4.792

5.  Enterobacter sakazakii targets DC-SIGN to induce immunosuppressive responses in dendritic cells by modulating MAPKs.

Authors:  Rahul Mittal; Silvia Bulgheresi; Claudia Emami; Nemani V Prasadarao
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

6.  Multiplex PCR assay targeting a diguanylate cyclase-encoding gene, cgcA, to differentiate species within the genus Cronobacter.

Authors:  L Carter; L A Lindsey; C J Grim; V Sathyamoorthy; K G Jarvis; G Gopinath; C Lee; J A Sadowski; L Trach; M Pava-Ripoll; B A McCardell; B D Tall; L Hu
Journal:  Appl Environ Microbiol       Date:  2012-11-09       Impact factor: 4.792

7.  Is Cronobacter sakazakii infection possible in an exclusively breastfed premature neonate in the neonatal intensive care unit?

Authors:  S Ravisankar; S S Syed; P Garg; J Higginson
Journal:  J Perinatol       Date:  2014-05       Impact factor: 2.521

8.  Putative Inv is essential for basolateral invasion of Caco-2 cells and acts synergistically with OmpA to affect in vitro and in vivo virulence of Cronobacter sakazakii ATCC 29544.

Authors:  Dilini Chandrapala; Kyumson Kim; Younho Choi; Amal Senevirathne; Dong-Hyun Kang; Sangryeol Ryu; Kwang-Pyo Kim
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

9.  Isolation of Cronobacter spp. (formerly Enterobacter sakazakii) from infant food, herbs and environmental samples and the subsequent identification and confirmation of the isolates using biochemical, chromogenic assays, PCR and 16S rRNA sequencing.

Authors:  Ziad W Jaradat; Qotaiba O Ababneh; Ismail M Saadoun; Nawal A Samara; Abrar M Rashdan
Journal:  BMC Microbiol       Date:  2009-10-27       Impact factor: 3.605

10.  Surveillance of stool samples for the presence of Enterobacter sakazakii among Korean people.

Authors:  Jung Beom Kim; Seung-Hak Cho; Yong Bae Park; Jung Bok Lee; Jong Chan Kim; Bok Kwon Lee; Hae Kyung Lee; Hiun Suk Chae
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.